MedTrace Logo

DELPHI in Subjects at Risk for Stroke and Dementia

NCT03884647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 335

Last updated 2022-09-14

No results posted yet for this study

Summary

The DELPhi system is a software device that is used for the noninvasive evaluation of brain plasticity and connectivity. The DELPhi software uses EEG and TMS devices as accessories. Standard electro-physiological acquisition is performed using TMS to evoke regional neuronal potentials measured as EEG data. TMS-EEG data is analyzed with regards to conventional, well established characteristics of neuronal network plasticity and connectivity.

Conditions

Interventions

DEVICE

DELPhI system

DELPhI software is acquiring and analyzing the TMS evoked response recorded with the EEG.

Sponsors & Collaborators

  • QuantalX Neuroscience

    lead INDUSTRY

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2022-05-06
Completion
2022-05-06

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03884647 on ClinicalTrials.gov